EGFR and chronic obstructive pulmonary disease: Additionally, a screening study of kinase inhibitors identified several compounds, including the ErbB inhibitors gefitinib, CP-724714, erbstatin, tyrphostin AG825, which can accelerate neutrophil apoptosis, indicating their potential as therapeutic agents in neutrophil-driven inflammatory diseases such as COPD [108].